Mirtazapine Tablet, Film Coated
Product Images NDC 55154-5355

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 55154-5355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mirtazapine Structural Formula (Image 01)

Mirtazapine Structural Formula (Image 01)
Chemical structure of mirtazapine showing its molecular rings and atomic connections as a line diagram.*
FDA Label Image

15mg Bag Label (Cf2aaac6 14b6 4a6d Adfe Ac4f80a9dff6 00)

15mg Bag Label (Cf2aaac6 14b6 4a6d Adfe Ac4f80a9dff6 00)
Label for Mirtazapine tablets USP 15 mg, film-coated tablets in a package of 10 tablets. The label includes manufacturer information from Mylan Pharmaceuticals Inc. and distributor information for Cardinal Health. It describes the tablet as beige, round, debossed with 'M' over '515'. Storage instructions and warnings for institutional use are noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.